Phaarmasia Fair Value
Phaarmasia (PHRMASI) average fair value is ₹189.01 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹81.25 (+132.63%), fair value range ₹12.86–₹466.01. See Phaarmasia P/B valuation to compare market price against book value per share.
Fair Value Analysis Export
PHRMASI Fair Value vs Current Price — Valuation Summary
PHRMASI average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Also explore Phaarmasia stock price data download to track price trends across different timeframes.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
PHRMASI Fair Value Analysis — Data Sources & Coverage
Phaarmasia financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit PHRMASI stock price BSE.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
PHRMASI vs Healthcare Sector Peers — P/E, P/B & Market Cap
Phaarmasia P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.